Study With [225Ac]Ac-FL-020 in mCRPC Participants

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1

מצבים רפואיים

Metastatic Castration-resistant Prostate Cancer

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • City of Hope Medical Center, Duarte, California, United States

    Contact: Study coordinator (Jennifer Simpson)
    Contact: Principal Investigator (Jeffrey Wong, MD)
  • Chao Family Comprehensive Cancer Center, Irvine, California, United States

    Contact: Study coordinator (Amanda Macaraeg) · macaraeg@hs.uci.edu · 714-456-8000
    Contact: Principal Investigator (Shyam Srinivas, MD)
  • University of Stanford, Stanford, California, United States

    Contact: Study coordinator (David G. Marcellus)
    Contact: Principal Investigator (Andrei Iagaru, MD)
    Contact: Principal Investigator (Hong Song, MD)
  • University Hospital of Cleveland, Cleveland, Ohio, United States

    Contact: Study coordinator (Cheryl L Eitman, Clinical research Nurse) · cheryl.eitman2@uhhospitals.org · +1 216 392-6512
    Contact: Principal Investigator (Pedro Barata, MD)
  • University of Virginia Cancer Center, Charlottesville, Virginia, United States

    Contact: Study coordinator (Robert Dreicer, Principal Investigator) · rd7va@UVAHealth.org · +1 434-924-1775
    Contact: Study coordinator (Christine P Martin, Clinical Trial Coordinator) · cmp2p@uvahealth.org
  • Princess Alexandra Hospital, Brisbane, Australia

    Contact: Study coordinator (Gillian Jagger)
    Contact: Principal Investigator (Aaron Hansen, MD)
  • Genesiscare Murdoch, Murdoch, Australia

    Contact: Study coordinator (Vicki Sproule)
    Contact: Principal Investigator (Joe Cardaci, MD)
  • MacQuarie University Clinical Trial Unit, Sydney, Australia

    Contact: Study coordinator (Luke Wood, Clinical Trial Coordinator) · luke.wood@mq.edu.au · +61 434 971 076
    Contact: Principal Investigator (Howard Gurney, Professor)
  • Beijing Cancer Hospital, Beijing, China

    Contact: Study coordinator (Jingjing Su) · jingjingsu@pharmaron.com · +86 02861508826
    Contact: Principal Investigator (Zhi Yang, Professor)
    Peng Du, MD (Sub-investigator)
  • Renji Shanghai Hospital, Shanghai, China

    Contact: Study coordinator (Vivien Hou) · vivienhou@pharmaron.com · +86 02861508826
    Contact: Principal Investigator (Wei Xu, MD)
    Contact: Principal Investigator (Jianjun Liu, MD)
  • Ankara Üniversitesi Tıp Fakültesi Cebeci Hastanesi Nükleer Tıp Anabilim Dalı, Ankara, Turkey (Türkiye)

    Contact: Study coordinator (Özlem Üstündag, Clinical Trial Coordinator) · ozlem_ustundag06@hotmail.com · +90 312 508 3879
    Contact: Principal Investigator (Yüksel Ürün)
מובילי המחקר
  • Full-Life Technologies GmbH

    Study Director

    Full-Life Technologies UK Limited